Rhode Island Hospital Rhode Island Hosp. (2) — Providence, Rhode Island

Rhode Island Hospital Rhode Island Hosp. (2) is a clinical research site located in Providence, Rhode Island, United States 02903.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Rhode Island Hospital Rhode Island Hosp. (2) has participated in 4 clinical trials.

Therapeutic areas: Tumor Pathway Activations Inhibited by Dovitinib, Tumors With Aberrations in ALK or ROS1, Tumors With CDK4/6 Pathway Activation.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rhode Island Hospital Rhode Island Hosp. (2)?

Rhode Island Hospital Rhode Island Hosp. (2) has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rhode Island Hospital Rhode Island Hosp. (2) conducted?

Rhode Island Hospital Rhode Island Hosp. (2) has 4 clinical trials on record. Their work covers Tumor Pathway Activations Inhibited by Dovitinib, Tumors With Aberrations in ALK or ROS1, Tumors With CDK4/6 Pathway Activation.

Is Rhode Island Hospital Rhode Island Hosp. (2) accredited by Crixeo Health?

Rhode Island Hospital Rhode Island Hosp. (2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rhode Island Hospital Rhode Island Hosp. (2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.